Closed
SectorHealthcare
58.58 1.88
24h
Min
57.98
Max
58.67
Income | -11M -77M |
|---|---|
Sales | -11M 11M |
EPS | -0.95 |
Profit margin | -667.602 |
Employees | 218 |
EBITDA | -21M -85M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +15.42% upside |
Next Earnings | 31 Oct 2025 |
|---|
Market Cap | 1.7B 4.3B |
|---|---|
Previous open | 56.7 |
Previous close | 58.58 |
By Acuity
50%
50%
147 / 371 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 67.59 USD 15.42%
High 88 USD
Low 53 USD
Based on 19 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$